Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.